222 related articles for article (PubMed ID: 16207861)
1. Torcetrapib and atorvastatin.
Shear CL
N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
[No Abstract] [Full Text] [Related]
2. Torcetrapib and atorvastatin--should marketing drive the research agenda?
Avorn J
N Engl J Med; 2005 Jun; 352(25):2573-6. PubMed ID: 15972861
[No Abstract] [Full Text] [Related]
3. Increasing HDL Cholesterol Levels.
Brewer HB
N Engl J Med; 2004 Apr; 350(15):1491-4. PubMed ID: 15071124
[No Abstract] [Full Text] [Related]
4. Effect of torcetrapib on the progression of coronary atherosclerosis.
Nissen SE; Tardif JC; Nicholls SJ; Revkin JH; Shear CL; Duggan WT; Ruzyllo W; Bachinsky WB; Lasala GP; Tuzcu EM;
N Engl J Med; 2007 Mar; 356(13):1304-16. PubMed ID: 17387129
[TBL] [Abstract][Full Text] [Related]
5. Torcetrapib and atorvastatin.
Hirsch RL
N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16211711
[No Abstract] [Full Text] [Related]
6. Torcetrapib and atorvastatin.
Green AM
N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16211710
[No Abstract] [Full Text] [Related]
7. Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
Brousseau ME; Schaefer EJ; Wolfe ML; Bloedon LT; Digenio AG; Clark RW; Mancuso JP; Rader DJ
N Engl J Med; 2004 Apr; 350(15):1505-15. PubMed ID: 15071125
[TBL] [Abstract][Full Text] [Related]
8. The IDEAL cholesterol: lower is better.
Cannon CP
JAMA; 2005 Nov; 294(19):2492-4. PubMed ID: 16287961
[No Abstract] [Full Text] [Related]
9. CETP inhibitors to increase HDL cholesterol levels.
Tall AR
N Engl J Med; 2007 Mar; 356(13):1364-6. PubMed ID: 17387130
[No Abstract] [Full Text] [Related]
10. Qualitative plaque stabilization but not quantitative plaque regression.
Nishigaki K
Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
[No Abstract] [Full Text] [Related]
11. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ; van Leuven SI; Burgess L; Evans GW; Kuivenhoven JA; Barter PJ; Revkin JH; Grobbee DE; Riley WA; Shear CL; Duggan WT; Bots ML;
N Engl J Med; 2007 Apr; 356(16):1620-30. PubMed ID: 17387131
[TBL] [Abstract][Full Text] [Related]
12. Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease.
Vita JA; Gokce N; Duffy SJ; Kahn D; Tomasian D; Palmisano J; Thomas S; Holbrook M; Keaney JF
Am J Cardiol; 2003 Apr; 91(7):857-60. PubMed ID: 12667571
[No Abstract] [Full Text] [Related]
13. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 inhibitors in atherosclerosis: the race is on.
Corson MA
Lancet; 2009 Feb; 373(9664):608-10. PubMed ID: 19231615
[No Abstract] [Full Text] [Related]
15. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
Einecke D
MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
[No Abstract] [Full Text] [Related]
16. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
Wamhoff BR; Dixon JL; Sturek M
J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
[TBL] [Abstract][Full Text] [Related]
17. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
[TBL] [Abstract][Full Text] [Related]
18. [Prevention in coronary heart disease. Can a CSE inhibitor arrest calcium deposits?].
MMW Fortschr Med; 2001 Apr; 143(14):44. PubMed ID: 11340911
[No Abstract] [Full Text] [Related]
19. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
